Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer

Clinical trial NCT02241551 · TERMINATED

Trial details

NCT number

NCT02241551

Sponsor

Nathan Bahary, MD

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2014-12-01

Primary completion

2017-03-03

Enrollment

2

View on ClinicalTrials.gov